SEARCH

SEARCH BY CITATION

References

  • 1
    Moller TR,Garwicz S,Barlow L,Falck Winther J,Glattre E,Olafsdottir G,Olsen JH,Perfekt R,Ritvanen A,Sankila R,Tulinius H. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001; 19: 317381.
  • 2
    Oeffinger KC,Eshelman DA,Tomlinson GE,Buchanan GR,Foster BM. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000; 88: 168795.
  • 3
    Sklar C,Whitton J,Mertens A,Stovall M,Green D,Marina N,Greffe B,Wolden S,Robison L. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85: 322732.
  • 4
    Hancock SL,Cox RS,McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325: 599605.
  • 5
    Spoudeas HA. Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur J Cancer 2002; 38: 174859; discussion 60–1.
  • 6
    Oberfield SE,Allen JC,Pollack J,New MI,Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr 1986; 108: 21923.
  • 7
    Rose SR,Lustig RH,Pitukcheewanont P,Broome DC,Burghen GA,Li H,Hudson MM,Kun LE,Heideman RL. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999; 84: 44729.
  • 8
    Metzger ML,Hudson MM,Somes GW,Shorr RI,Li CS,Krasin MJ,Shelso J,Pui CH,Howard SC. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 2006; 24: 151621.
  • 9
    Teppo L,Pukkala E,Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 3659.
  • 10
    Helin-Salmivaara A,Klaukka T,Huupponen R. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmacol 2003; 59: 47782.
  • 11
    Breslow NE,Day NE.Statistical methods in cancer research,Vol. 2: The design and analysis of cohort studies. Lyon, France: IARC, 1987; 1406.
  • 12
    Schmiegelow M,Feldt-Rasmussen U,Rasmussen AK,Lange M,Poulsen HS,Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003; 88: 314954.
  • 13
    Heikens J,Michiels EM,Behrendt H,Endert E,Bakker PJ,Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 1998; 34: 15927.
  • 14
    Mulhern RK,Merchant TE,Gajjar A,Reddick WE,Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5: 399408.
  • 15
    Berger C,Le-Gallo B,Donadieu J,Richard O,Devergie A,Galambrun C,Bordigoni P,Vilmer E,Plouvier E,Perel Y,Michel G,Stephan JL. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005; 35: 9915.
  • 16
    Flandin I,Hartmann O,Michon J,Pinkerton R,Coze C,Stephan JL,Fourquet B,Valteau-Couanet D,Bergeron C,Philip T,Carrie C. Impact of TBI on late effects in children treated by megatherapy for stage IV neuroblastoma. A study of the French society of pediatric oncology. Int J Radiat Oncol Biol Phys 2006; 64: 142431.
  • 17
    Faraci M,Barra S,Cohen A,Lanino E,Grisolia F,Miano M,Foppiano F,Sacco O,Cabria M,De Marco R,Stella G,Dallorso S, et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63: 156875.
  • 18
    Livesey EA,Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989; 64: 5935.
  • 19
    Ogilvy-Stuart AL,Shalet SM,Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991; 119: 7337.
  • 20
    Rose SR,Schreiber RE,Kearney NS,Lustig RH,Danish RK,Burghen GA,Hudson MM. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 2004; 17: 5566.
  • 21
    Acharya S,Sarafoglou K,LaQuaglia M,Lindsley S,Gerald W,Wollner N,Tan C,Sklar C. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003; 97: 2397403.